about
Dietary supplements for dysmenorrhoeaHypnotherapy for smoking cessationCytisine versus nicotine for smoking cessationStudy of natural health product adverse reactions (SONAR): active surveillance of adverse events following concurrent natural health product and prescription drug use in community pharmaciesConsumers of natural health products: natural-born pharmacovigilantes?Study protocol for a non-inferiority trial of cytisine versus nicotine replacement therapy in people motivated to stop smoking.St John's wort (Hypericum perforatum L.): a review of its chemistry, pharmacology and clinical properties.Echinacea species (Echinacea angustifolia (DC.) Hell., Echinacea pallida (Nutt.) Nutt.,Echinacea purpurea (L.) Moench): a review of their chemistry, pharmacology and clinical properties.Adverse effects profile of the herbal antidepressant St. John's wort (Hypericum perforatum L.).Quality, efficacy and safety of complementary medicines: fashions, facts and the future. Part I. Regulation and quality.Quality, efficacy and safety of complementary medicines: fashions, facts and the future. Part II: Efficacy and safetyMedicinal plants used for menstrual disorders in Latin America, the Caribbean, sub-Saharan Africa, South and Southeast Asia and their uterine properties: a review.Different standards for reporting ADRs to herbal remedies and conventional OTC medicines: face-to-face interviews with 515 users of herbal remedies.Improving the quality of reporting of randomized controlled trials evaluating herbal interventions: implementing the CONSORT statement [corrected].Natural health product-drug interaction tool: A scoping review.How well do pharmacists know their patients? A case report highlighting natural health product disclosure.Pharmacy study of natural health product adverse reactions (SONAR): a cross-sectional study using active surveillance in community pharmacies to detect adverse events associated with natural health products and assess causality.Assessing safety of herbal products for menopausal complaints: an international perspective.United States pharmacopeia safety evaluation of spirulina.Herbal medicines: challenges in the modern world. Part 1. Australia and New Zealand.Characteristics and practices of Traditional Chinese Medicine retail shops in London, UK: A cross-sectional study using an observational approach.The impact of New Zealand's 2008 prohibition of piperazine-based party pills on young people's substance use: results of a longitudinal, web-based study.Pharmacovigilance of herbal medicines: the potential contributions of ethnobotanical and ethnopharmacological studies.Pharmacists' views on and experiences with bowel cancer screening kits in Auckland, New Zealand.Community pharmacists' views on the regulation of complementary medicines and complementary-medicines practitioners: a qualitative study in New Zealand.Introduction to the research methods in CAM series.Recommendations for reporting randomized controlled trials of herbal interventions: Explanation and elaboration.Guidelines for submitting adverse event reports for publication.Homeopathy for postoperative ileus? A meta-analysis.Cytisine Versus Nicotine for Smoking CessationArticles on Complementary Medicine in the Mainstream Medical LiteratureReporting natural health product related adverse drug reactions: is it the pharmacist's responsibility?Guidelines for Submitting Adverse Event Reports for PublicationA Pilot Randomised, Open, Uncontrolled, Clinical Study of Two Dosages of St John’s Wort (Hypericum perforatum) Herb Extract (LI-160) as an Aid to Motivational/Behavioural Support in Smoking CessationMEETING THE IMPACT OF THE TRADITIONAL HERBAL MEDICINAL PRODUCTS DIRECTIVEReport of the UK DURG regional meeting on New Horizons in PharmacovigilanceThe International Society of Pharmacovigilance (ISoP) Special Interest Group on Herbal and Traditional Medicines: Towards Progress in Pharmacovigilance for Herbal and Traditional Medicines and Other "Natural Health" Products
P50
Q24186015-3E4C01ED-E8F3-4CB1-B1C2-A2264ED24C4BQ24234471-C4E9AC82-46DA-4C89-BA3F-C3F98BD6B76DQ28254090-C9171067-3F88-4627-9AF3-16921D08F2E5Q28484140-48024D6D-0A23-4EC9-AABD-B9B835E0C0DAQ33534493-FF03D98A-4F1D-4D4D-BB23-A011BE169232Q34079637-53E29A85-4EE8-4476-8846-22D430FD0A7AQ34259736-2DD165B2-4C70-4960-991E-16EED3B27663Q34443230-2E8BABD3-1AAF-4ECB-BB08-AF829F9B262AQ34484334-C61B9308-3E11-4855-A77B-7E8C3C668F83Q35083578-9FED2BB2-C772-4BA8-A3DC-DC7B76B59B47Q35101633-7B5BC3EB-E6D6-49F5-8C67-C48B5E0370A2Q35197062-9204D1E6-400A-4F61-94A0-E2E15651DF10Q35802401-AAD81C2F-8EB0-43D9-B3BC-5D8FAAFE2786Q36509938-91EE81B0-1C5B-4CA0-A2C8-99780730D193Q36744650-FF177088-1ED4-4F10-B15F-82D8F497A813Q37073929-27AB82C0-FA8A-4B12-A223-9916F22BEB57Q37684795-7C826298-F805-4FEF-B808-D9E447023734Q37745465-3D173843-7B7C-42D8-8C15-95A70957EB12Q37906655-56C3D3E6-E6EA-4D4F-9BE3-CD3926E38B4DQ38806124-321B26DF-60CC-4EFB-B17E-1FEC07A8F4ECQ38981100-61F71B72-9FF4-4BB2-A919-CA778F1A7903Q43923599-945B4CF1-8115-4769-808B-9948193FBE4BQ44019202-AD50EB2E-3C2F-4ACE-9D65-94E6EC511239Q44250293-BB5E6F45-7078-490D-8B55-1F44923B5382Q47557155-05371DD2-97EE-4AC9-85B9-1D0DA421280DQ52858470-1F7A3D3E-D875-4601-8C34-8103A65D364DQ53011348-03ECBB55-6B9C-4D64-87B6-5F5B83109479Q53186313-ADF6EE21-E39E-4996-AD77-8DF57759E508Q55067354-F9300451-652F-4228-841B-B75CAC5071BDQ57830742-18532BEB-5515-4970-8811-76CFC8E6248FQ57914476-80C0EC8F-3012-47DB-9708-D2D3F6C8A577Q61728426-7B4B34CA-7FBE-46C4-AFFD-E45DF1B4C7EAQ61728446-A7CAEF9B-4BC4-4555-AA50-8FC01145B530Q61728451-026BFD67-989E-46CB-A531-C91621C5266FQ61728456-010DA5F3-4CBB-4439-B96E-C348A4AA1E4EQ82691217-774F914B-6B82-4BCC-A6A7-ED3EC51AC283Q93202103-0370F2E1-48CE-45F8-B520-30D931B08FA3
P50
description
hulumtuese
@sq
researcher
@en
ricercatrice
@it
wetenschapper
@nl
հետազոտող
@hy
name
Joanne Barnes
@ast
Joanne Barnes
@en
Joanne Barnes
@es
Joanne Barnes
@nl
Joanne Barnes
@sl
type
label
Joanne Barnes
@ast
Joanne Barnes
@en
Joanne Barnes
@es
Joanne Barnes
@nl
Joanne Barnes
@sl
prefLabel
Joanne Barnes
@ast
Joanne Barnes
@en
Joanne Barnes
@es
Joanne Barnes
@nl
Joanne Barnes
@sl
P214
P244
P906
P106
P1153
7402288423
P21
P214
P244
nb2002047381
P31
P496
0000-0002-1522-8433
P569
1966-01-01T00:00:00Z
P734
P735
P7859
lccn-nb2002047381